Kuzuya, T.; Kawabe, N.; Muto, H.; Tachi, Y.; Ukai, T.; Wada, Y.; Komura, G.; Nakano, T.; Tanaka, H.; Nakaoka, K.;
et al. Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response. Curr. Oncol. 2024, 31, 6218-6231.
https://doi.org/10.3390/curroncol31100463
AMA Style
Kuzuya T, Kawabe N, Muto H, Tachi Y, Ukai T, Wada Y, Komura G, Nakano T, Tanaka H, Nakaoka K,
et al. Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response. Current Oncology. 2024; 31(10):6218-6231.
https://doi.org/10.3390/curroncol31100463
Chicago/Turabian Style
Kuzuya, Teiji, Naoto Kawabe, Hisanori Muto, Yoshihiko Tachi, Takeshi Ukai, Yuryo Wada, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka,
and et al. 2024. "Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response" Current Oncology 31, no. 10: 6218-6231.
https://doi.org/10.3390/curroncol31100463
APA Style
Kuzuya, T., Kawabe, N., Muto, H., Tachi, Y., Ukai, T., Wada, Y., Komura, G., Nakano, T., Tanaka, H., Nakaoka, K., Ohno, E., Funasaka, K., Nagasaka, M., Miyahara, R., & Hirooka, Y.
(2024). Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response. Current Oncology, 31(10), 6218-6231.
https://doi.org/10.3390/curroncol31100463
